ESMO Virtual Journal Club: March 2025

This content is for ESMO members only.

Login

Learn more about how you can join ESMO

Programme

• 19 March 2025

Welcome and introduction

Sylvie Lorenzen

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Michail Ignatiadis

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer

Claire Gallois

Live Q&A and Discussion

All speakers

• 

  Sylvie Lorenzen

  Chair

  Klinikum rechts der Isar
  Department of Hematology and Oncology
  Technical University Munich
• 

  Michail Ignatiadis

  Speaker

  Institut Jules Bordet
  Hôpital Universitaire de Bruxelles
• 

  Claire Gallois

  Speaker

  Hôpital européen Georges-Pompidou

Description

This ESMO Virtual Journal Club Webinar focused on three newly published studies, with an aim to enhance understanding and application of the latest research in the field.

This webinar aimed to discuss and evaluate notable recent publications on the topic of Advanced Breast Cancer and Microsatellite-Instability–High Metastatic Colorectal Cancer:

Komal L. Jhaveri, Patrick Neven et al. Imlunestrant with or without Abemaciclib in Advanced Breast Cancer. The New England Journal of Medicine.

Thierry André,Elena Elez, Eric Van Cutsem et al. Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer. The New England Journal of Medicine.

Learning objectives

• To discuss and critically evaluate notable recent publications.
• To enhance the understanding and application of the latest research in the field.
• To assess the study’s robustness, its significance to oncology practice, limitations, and its place within existing research.
• To identify and highlight any unclear aspects or unmet needs.